HB4834 - 104th General Assembly (2025-2026)

CONTROLLED SUB-TESTOSTERONE
Last Action
3/25/2026 - House: Placed on Calendar 2nd Reading - Short Debate
Statutes Amended In Order of Appearance
720 ILCS 570/316  
720 ILCS 570/316.2 new  
Synopsis As Introduced
Amends the Illinois Controlled Substances Act. Provides that the Prescription Monitoring Program does not apply to testosterone, mifepristone, misoprostol, GnRH analogues, or estrogen. Provides that the Department of Human Services shall purge from the records of the Prescription Monitoring Program all existing information concerning the prescribing or dispensing of testosterone, including any such information contained in the central repository or database, on or before January 1, 2027, and shall ensure that no further records concerning the prescribing and dispensing of testosterone are created or maintained by the Prescription Monitoring Program. Provides that the Department shall update and adopt rules consistent with the provision no later than January 1, 2027. Effective immediately.
Actions
DateChamberAction
2/03/2026HouseFiled with the Clerk by Rep. Kelly M. Cassidy
2/06/2026HouseFirst Reading
2/06/2026HouseReferred to Rules Committee
2/13/2026HouseAdded Chief Co-Sponsor Rep. Kevin John Olickal
2/18/2026HouseAdded Co-Sponsor Rep. Daniel Didech
3/09/2026HouseAdded Co-Sponsor Rep. Joyce Mason
3/13/2026HouseAdded Co-Sponsor Rep. Justin Cochran
3/18/2026HouseAssigned to Human Services Committee
3/20/2026HouseAdded Co-Sponsor Rep. Maura Hirschauer
3/20/2026HouseAdded Co-Sponsor Rep. Anna Moeller
3/20/2026HouseAdded Co-Sponsor Rep. Amy Briel
3/24/2026HouseAdded Co-Sponsor Rep. Theresa Mah
3/25/2026HouseDo Pass / Short Debate Human Services Committee; 008-004-000
3/25/2026HousePlaced on Calendar 2nd Reading - Short Debate
3/26/2026HouseAdded Co-Sponsor Rep. Michael Crawford
3/26/2026HouseAdded Co-Sponsor Rep. Dagmara Avelar